Table 4a. Progression Free Results for Non-Muscle Invasive Bladder Cancer.
Univariate Analyses1 | Multivariate Analyses1 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Median2 | HR3 | LCL | UCL | p4 | n | Median2 | HR3 | LCL | UCL | p4 | |
Age (years) | ||||||||||||
≤ 65 | 183 | 41.7 | 1.00 | 181 | 36.8 | 1.00 | ||||||
> 65 | 317 | 14.6 | 1.84 | 1.29 | 2.63 | .0008 | 317 | 15.9 | 1.67 | 1.16 | 2.40 | .006 |
Gender | ||||||||||||
Female | 95 | 21.2 | 1.00 | 95 | 18.2 | 1.00 | ||||||
Male | 405 | 22.1 | 0.98 | 0.66 | 1.46 | .92 | 403 | 22.6 | 0.88 | 0.59 | 1.32 | .54 |
Tumor Grade | ||||||||||||
Low | 219 | 50.5 | 1.00 | 219 | 36.2 | 1.00 | ||||||
High | 279 | 11.4 | 2.47 | 1.74 | 3.52 | <.0001 | 279 | 14.5 | 1.74 | 1.04 | 2.92 | .03 |
Tumor Stage | ||||||||||||
Ta or Tis | 253 | 44.6 | 1.00 | 252 | 27.8 | 1.00 | ||||||
T1 | 247 | 11.0 | 2.34 | 1.68 | 3.27 | <.0001 | 246 | 16.7 | 1.42 | 0.87 | 2.33 | .16 |
Lymph Nodes | ||||||||||||
N0 or NX | 487 | 23.5 | 1.00 | 486 | 22.8 | 1.00 | ||||||
N1 | 13 | 1.3 | 5.98 | 3.22 | 11.11 | <.0001 | 12 | 2.8 | 4.25 | 2.20 | 8.21 | <.0001 |
ANG | ||||||||||||
0-2 | 408 | 25.6 | 1.00 | 408 | 24.3 | 1.00 | ||||||
3-4 | 29 | 22.9 | 1.08 | 0.55 | 2.13 | .83 | 28 | 26.2 | 0.97 | 0.47 | 2.00 | .92 |
MMP-2 | ||||||||||||
0-2 | 175 | 26.1 | 1.00 | 173 | 25.5 | 1.00 | ||||||
3-4 | 281 | 21.6 | 1.06 | 0.75 | 1.49 | .75 | 281 | 20.4 | 1.09 | 0.77 | 1.55 | .63 |
5-6 | 2 | 17.8 | 1.12 | 0.56 | 2.22 | 2 | 16.2 | 1.19 | 0.59 | 2.39 | ||
p53 | ||||||||||||
0-2 | 284 | 29.8 | 1.00 | 284 | 23.6 | 1.00 | ||||||
3-4 | 173 | 18.3 | 1.33 | 1.01 | 1.75 | .04 | 173 | 21.5 | 1.08 | 0.81 | 1.44 | .60 |
5-6 | 24 | 11.3 | 1.77 | 1.03 | 3.06 | 24 | 19.5 | 1.17 | 0.65 | 2.08 | ||
Rb | ||||||||||||
0-2 | 97 | 23.6 | 1.00 | 96 | 22.4 | 1.00 | ||||||
3-4 | 347 | 27.4 | 0.93 | 0.62 | 1.40 | .74 | 347 | 28.0 | 0.89 | 0.58 | 1.35 | .58 |
5-6 | 3 | 31.7 | 0.87 | 0.38 | 1.97 | 3 | 35.1 | 0.79 | 0.34 | 1.83 | ||
PAI-1 | ||||||||||||
0-2 | 192 | 20.8 | 1.00 | 191 | 17.3 | 1.00 | ||||||
3-4 | 277 | 22.2 | 0.89 | 0.65 | 1.23 | .49 | 277 | 26.0 | 0.72 | 0.51 | 1.02 | .06 |
5-6 | 8 | 23.6 | 0.80 | 0.42 | 1.50 | 8 | 39.2 | 0.52 | 0.26 | 1.03 |
1Univariate analyses are unadjusted. Multivariate analyses are adjusted for age, sex, tumor grade, tumor stage, and lymph nodes.
2Median is the median years progression free as estimated from a parametric model.
3HR is the hazard ratio from a semiparametric (Cox proportional hazards) model. The 95% confidence limits (LCL and UCL) are shown.
4The expression p-values are for trend.